Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. [electronic resource] by
- Ressing, M E
- Sette, A
- Brandt, R M
- Ruppert, J
- Wentworth, P A
- Hartman, M
- Oseroff, C
- Grey, H M
- Melief, C J
- Kast, W M
Producer: 19950622
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 154
Availability: No items available.
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape. [electronic resource] by
- Toes, R E
- Feltkamp, M C
- Ressing, M E
- Vierboom, M P
- Blom, R J
- Brandt, R M
- Hartman, M
- Offringa, R
- Melief, C J
- Kast, W M
Producer: 19960307
In:
Biochemical Society transactions vol. 23
Availability: No items available.
|
|
12.
|
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope. [electronic resource] by
- Ressing, M E
- van Driel, W J
- Celis, E
- Sette, A
- Brandt, M P
- Hartman, M
- Anholts, J D
- Schreuder, G M
- ter Harmsel, W B
- Fleuren, G J
- Trimbos, B J
- Kast, W M
- Melief, C J
Producer: 19960301
In:
Cancer research vol. 56
Availability: No items available.
|
|
13.
|
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. [electronic resource] by
- De Bruijn, M L
- Schuurhuis, D H
- Vierboom, M P
- Vermeulen, H
- de Cock, K A
- Ooms, M E
- Ressing, M E
- Toebes, M
- Franken, K L
- Drijfhout, J W
- Ottenhoff, T H
- Offringa, R
- Melief, C J
Producer: 19980319
In:
Cancer research vol. 58
Availability: No items available.
|
|
14.
|
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma. [electronic resource] by
- Ressing, M E
- van Driel, W J
- Brandt, R M
- Kenter, G G
- de Jong, J H
- Bauknecht, T
- Fleuren, G J
- Hoogerhout, P
- Offringa, R
- Sette, A
- Celis, E
- Grey, H
- Trimbos, B J
- Kast, W M
- Melief, C J
Producer: 20000615
In:
Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 23
Availability: No items available.
|
|
15.
|
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes. [electronic resource] by
- van der Burg, S H
- Ressing, M E
- Kwappenberg, K M
- de Jong, A
- Straathof, K
- de Jong, J
- Geluk, A
- van Meijgaarden, K E
- Franken, K L
- Ottenhoff, T H
- Fleuren, G J
- Kenter, G
- Melief, C J
- Offringa, R
Producer: 20010419
In:
International journal of cancer vol. 91
Availability: No items available.
|
|
16.
|
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial. [electronic resource] by
- van Driel, W J
- Ressing, M E
- Kenter, G G
- Brandt, R M
- Krul, E J
- van Rossum, A B
- Schuuring, E
- Offringa, R
- Bauknecht, T
- Tamm-Hermelink, A
- van Dam, P A
- Fleuren, G J
- Kast, W M
- Melief, C J
- Trimbos, J B
Producer: 19991105
In:
European journal of cancer (Oxford, England : 1990) vol. 35
Availability: No items available.
|